Interactive presentation

Patient Interview

Barbara P. Yawn, MD, MSc, FAAFP
Suggested Readings

Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials.

Decramer M, et al. Lancet Respir Med. 2014;2(6):472-486.

Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Hurst JR, et al. N Engl J Med. 2010;363(12):1128-1138.

Effect of early follow-up after hospital discharge on outcomes in patients with heart failure or chronic obstructive pulmonary disease: a systematic review.

Health Quality Ontario. Ont Health Technol Assess Ser. 2017;17(8):1-37.

Influence of COPD Assessment Text (CAT) evaluation and rehabilitation education guidance on the respiratory and motor functions of COPD patients.

Liu J, et al. Open Med (Wars). 2015;10(1):394-398.

Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.

Mahler DA, et al. Thorax. 2012;67(9):781-788.

Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.

Martinez FJ, et al. Lancet. 2015;385(9971):857-866.

Factors affecting chronic obstructive pulmonary disease early rehospitalization.

Nantsupawat T, et al. Chron Respir Dis. 2012;9(2):93-98.

Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.

Puhan MA, et al. Cochrane Database Syst Rev. 2016;12:CD005305.

The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.

Schnell K, et al. BMC Pulm Med. 2012;12:26.

Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease.

Sharma G, et al. Arch Intern Med. 2010;170(18):1664-1670.

An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Spruit MA, et al. Am J Respir Crit Care Med. 2013;188(8):e13-e64.

Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.

Yawn BP, et al. Int J Chron Obstruct Pulmon Dis. 2012;7:495-502.

Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.

Yawn BP, Thomashow B. Int J Gen Med. 2011;4:665-676.

Linked Resources


Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017.

The COPD Foundation Pocket Consultant Guide

COPD Foundation Guide to COPD Diagnosis and Treatment (Rennard S, et al. COPD. 2013;10(3):378-389).

Patient Resources

American College of Chest Physicians (CHEST Foundation)

The mission of CHEST Foundation is to develop resources to champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research.

American Lung Association

The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy, and research.

COPD Action Plan

Patients and health care providers should complete this action plan together. This plan should be discussed at each follow-up visit and updated as needed.

COPD Foundation

The COPD Foundation’s mission is to prevent and cure chronic obstructive pulmonary disease and to improve the lives of all people affected by COPD.

Global Initiative for Chronic Obstructive Lung Disease (GOLD)

GOLD partners with health care professionals and public health officials to raise awareness of COPD and to improve prevention and treatment of this lung disease for patients around the world.

National Jewish Health

National Jewish Health is at the forefront of research and medicine, integrating the latest scientific discoveries with coordinated care for lung, heart, and immune diseases. Online instructional videos demonstrate how to properly use inhaled medications for lung diseases.

Clinical Assessment Tools

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Bestall JC, et al. Thorax. 1999;54(7):581-586.

Development and first validation of the COPD Assessment Test.

Jones PW, et al. Eur Respir J. 2009;34(3):648-654.

Related activities

Ongoing Monitoring of Patients with COPD

Module 1 of 4

Faculty: Barry J. Make, MD, FACP, FCCP, FACVPR; Barbara P. Yawn, MD, MSc, FAAFP
Release: 10/18/2017
Expiration: 10/18/2018

Maximizing Function and Quality of Life in Patients with COPD

Module 2 of 4

Faculty: Barry J. Make, MD, FACP, FCCP, FACVPR; Barbara P. Yawn, MD, MSc, FAAFP
Release: 10/18/2017
Expiration: 10/18/2018

Individualizing Maintenance Therapy for Patients with COPD

Module 3 of 4

Faculty: Barry J. Make, MD, FACP, FCCP, FACVPR; Barbara P. Yawn, MD, MSc, FAAFP
Release: 12/01/2017
Expiration: 12/01/2018

Optimizing Patient-Clinician Communication

Module 4 of 4

Faculty: Barry J. Make, MD, FACP, FCCP, FACVPR; Barbara P. Yawn, MD, MSc, FAAFP
Release: 04/30/2018
Expiration: 04/29/2019